The World Health Organization declared an end to the COVID-19 pandemic’s emergency status. The move marks a milestone as the pandemic recedes and the coronavirus becomes routine. (The Wall Street Journal)
The Food and Drug Administration’s reviewers raised concerns about allowing over-the-counter use of Perrigo’s birth control pill. Next week, the agency’s outside experts are expected to discuss an over-the-counter request from a French company that makes a contraceptive called Opill. (ABC News)
Elon Musk’s brain-implant venture has filled an animal-research oversight board with company insiders who may stand to benefit financially as the firm reaches development goals, according to an exposé. The membership of the panel at Musk’s company, Neuralink, raises questions about potential violations of conflict-of-interest regulations aimed at protecting research integrity. (Reuters)
Horizon Pharmaceuticals’ stock gained on news that its acquisition by Amgen may close on May 23. The Irish biotech’s stock inched up 1.1% on a report that the deal may close in a couple of weeks. (Seeking Alpha)
Aerami Therapeutics announced Friday that its CEO Lisa Yañez passed away in a car crash. Investigators said the driver struck a tree and that the cause of the crash is under investigation. (WRAL)
